Wang Laoji's "Red and Green Controversy" will have a conclusion or a war this month

Wang Laoji's "Red-Green Controversy" may conclude this month. It is reported that the Guangyao Group, which owns the trademark rights of Wang Lao Ji Mainland (hereinafter referred to as "Guangxi Pharmaceutical"), has submitted a dispute arbitration application to the China International Economic and Trade Arbitration Commission (referred to as "Zhongzhong"), and will officially hold arbitration in Beijing at the end of December. The focus of the dispute with the owner of Red Can Wang Lao Ji Jia Duo Bao Group is on whether Li Yuanming, former vice chairman of the former Guangyao Group, accepted the bribe and whether the ten-year contract for the Wang Laoji trademark contract was valid. It is reported that relevant departments in Guangzhou have stepped in.

Although from the "Contract Law", the drug's chances are high, but there may be another embarrassing situation, that is, the JDB Group and its parent company, Hong Kong Hongdao Group, will recover the mark through Wang Lao Ji's descendants in Hong Kong and overseas. The right to use.

Guangpong believes that due to the suspicion of bribery during the signing process of the renewal of the supplementary contract and the sale of state-owned intangible assets, the contract should be regarded as an invalid contract. According to the "Contract Law," a contract can be regarded as invalid if one party enters into a contract with fraudulent or coercive means that impairs the country's interests or maliciously colludes and harms the interests of the country, the collective or a third party.

According to internal information of Guangpong, both parties have now appointed arbitrators. The court at the end of December, unless the arbitrator cannot hold the court due to special reasons, even if Hong Dao does not attend, he can still pronounce the case as usual. The reporter learned from people close to Guangzhou Pharmaceutical that due to this "red-green dispute" involving state-owned assets, relevant departments in Guangzhou have stepped in. The Guangzhou Public Office Law Firm has sole responsibility for this matter.

Faced with the resolute attitude of Guangzhou Pharmaceutical, Tian Dawei, Chief Representative of Corporate Communications at JDB Group, responded yesterday: “We are not making any external comments and responses regarding Wang Laoji’s business.” Recently, there are reports that JDB has proposed High-price renewal, stock renewals and other methods have sought to reach cooperation with the GP Group, but they have all been rejected by Guangpah.

At the same time, the reporter also learned that currently, Guangzhou Pharmaceuticals only owns Wanglaoji’s Mainland trademark ownership, and Wang Miyi, the fifth generation descendant of Hong Kong’s Wong Lo Kat, has trademark registration rights in Hong Kong and overseas.

In November 2002, Guangyao and Wang Jianyi signed a 10-year agreement on the use of rights. During this period, Guangyao "Wang Lao Ji" series of products can be sold in the aforementioned Malaysia and other regions. At the same time, Guangzhou Wang Lao Ji will pay the other party a trademark use fee according to a certain percentage of sales.

Now that the lease is about to expire, if Jiaduobao loses the case, the company may use Wang Laiyi, the founder of Wang Laoji, to master the trademark rights in Hong Kong and overseas. By then, Guangyao “Green Box” Wang Lao Ji will face exit from Hong Kong and overseas. Hey.